<DOC>
	<DOCNO>NCT02667353</DOCNO>
	<brief_summary>To study potential neurorestorative effect electroconvulsive therapy ( ECT ) depress patient measure brain derive neurotrophic factor ( BDNF ) serum level hippocampal volume severely depress patient receive ECT .</brief_summary>
	<brief_title>Neurorestorative Effects Electroconvulsive Therapy ( ECT ) Patients With Severe Late Life Depression</brief_title>
	<detailed_description>The investigator want study potential neurorestorative effect electroconvulsive therapy ( ECT ) depress patient measure brain derive neurotrophic factor ( BDNF ) serum level hippocampal volume severely depress patient receive ECT . Clinical study severely depress patient show antidepressant ECT increase Brain Derived Neurotrophic Factor ( BDNF ) serum level . BDNF serum level measure , ECT . In animal study increase serum BDNF show induce hippocampal mossy fiber sprout investigator want study phenomenon human . Recently , volumetric magnetic resonance imaging study show increased hippocampal volume patient depression . Hippocampal volume determine magnetic resonance imaging scanning include voxel base morphometry . Severe depression accompany dysfunction hypothalamus pituitary adrenal ( HPA ) axis . Cortisol several hormone psychotropic effect , excesses deficiency induce state mania depression . High level cortisol suppress hippocampal neurogenesis . Animal model show suppressive effect cortisol hippocampal neurogenesis could reverse normal level electroconvulsive stimulation , animal model ECT . This animal study good accordance clinical finding . The investigator hypothesize follow : Increase brain-derived neurotrophic factor serum level induce electroconvulsive therapy associate remission correlate neurorestorative effect , increase hippocampal volume . Non- response ECT explain either low BDNF serum level regardless hippocampus size , ( advance ) medial temporal lobe atrophy ( beyond point return ) despite increase BDNF serum level . Additionally , four relevant functional candidate gene examine , base putative role neurotrophic process and/or treatment response depression : brain derive neurotrophic factor gene , serotonin transporter gene , vascular endothelial growth factor gene apolipoprotein gene . The investigator also evaluate cognitive psychomotor change follow electroconvulsive therapy give clinical relevance late life depression .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Etomidate</mesh_term>
	<mesh_term>Succinylcholine</mesh_term>
	<criteria>Patients consider suitable diagnose severe depression accord Diagnostic Statistical Manual IV ( DSMIV criterion ) 55 year age . another major psychiatric illness , ( history ) major neurological illness ( include Parkinson 's disease , stroke , dementia ) metal implant preclude Magnetic Resonance Imaging ( MRI ) . Subjects include University Psychiatric Center Katholieke Universiteit Leuven ( KU Leuven ) , Belgium Geestelijke Gezondheidszorg Geest ( GGZinGeest ) , Amsterdam , Netherlands . The project part project Mood Disorders Elderly Electroconvulsive therapy ( MODECT ) .</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>electroconvulsive</keyword>
	<keyword>hippocampus</keyword>
	<keyword>elderly</keyword>
	<keyword>work mechanism</keyword>
</DOC>